Advancing Alzheimer's disease diagnosis, treatment, and care: Recommendations from the Ware Invitational Summit

Alzheimer's and Dementia

Volumn 8, Issue 5, 2012, Pages 445-452

  Naylor, Mary D ^a,b   Karlawish, Jason H ^a,c,d   Arnold, Steven E ^a,c   Khachaturian, Ara S ^e   Khachaturian, Zaven S ^e   Lee, Virginia M Y ^a,c   Baumgart, Matthew ^f   Banerjee, Sube ^g   Beck, Cornelia ^h   Blennow, Kaj ⁱ   Brookmeyer, Ron ^j   Brunden, Kurt R ^a,c   Buckwalter, Kathleen C ^k   Comer, Meryl ^l   Covinsky, Kenneth ^m   Feinberg, Lynn Friss ⁿ   Frisoni, Giovanni ^o   Green, Colin ^p   Guimaraes, Renato Maia ^q   Gwyther, Lisa P ^r   Hefti, Franz F ^s   Hutton, Michael ^t   Kawas, Claudia ^u   Kent, David M ^v   Kuller, Lewis ^w   Langa, Kenneth M ^x   Mahley, Robert W ^y   Maslow, Katie ^z   Masters, Colin L ^aa   Meier, Diane E ^ab   Neumann, Peter J ^v   Paul, Steven M ^ac   Petersen, Ronald C ^ad   Sager, Mark A ^ae   Sano, Mary ^ab   Schenk, Dale ^af   Soares, Holly ^ag   Sperling, Reisa A ^ah   Stahl, Sidney M ^ai   Van Deerlin, Vivianna ^a,c   Stern, Yaakov ^aj   Weir, David ^x   Wolk, David A ^c   Trojanowski, John Q ^a,c   more..

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA SCHOOL OF NURSING   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e King's College London ^*  (United States)

^f ALZHEIMER'S ASSOCIATION   (United States)

^g KING'S COLLEGE LONDON   (United Kingdom)

^h UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

ⁱ UNIVERSITY OF GOTHENBURG   (Sweden)

^j UNIVERSITY OF CALIFORNIA   (United States)

^k UNIVERSITY OF IOWA   (United States)

^l Geoffrey Beene Foundation Alzheimer's Initiative   (United States)

^m UNIVERSITY OF CALIFORNIA   (United States)

ⁿ AARP   (United States)

^o IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

^p UNIVERSITY OF EXETER   (United Kingdom)

^q International Association of Gerontology and Geriatrics   (Brazil)

^r DUKE UNIVERSITY   (United States)

^s Acumen Pharmaceuticals Inc   (United States)

^t ELI LILLY AND COMPANY   (United States)

^u UNIVERSITY OF CALIFORNIA   (United States)

^v TUFTS MEDICAL CENTER   (United States)

^w UNIVERSITY OF PITTSBURGH   (United States)

^x UNIVERSITY OF MICHIGAN   (United States)

^y GLADSTONE INSTITUTES   (United States)

^z INSTITUTE OF MEDICINE   (United States)

^aa UNIVERSITY OF MELBOURNE   (Australia)

^ab MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^ac WEILL CORNELL MEDICAL COLLEGE   (United States)

^ad MAYO CLINIC   (United States)

^ae UNIVERSITY OF WISCONSIN MADISON   (United States)

^af ELAN PHARMACEUTICALS   (United States)

^ag BRISTOL MYERS SQUIBB   (United States)

^ah HARVARD MEDICAL SCHOOL   (United States)

^ai Independent Researcher   (United States)

^aj Och Spine at New York Presbyterian Hospitals   (United States)

more..

Author keywords

Alzheimer's disease; Dementia; Health policy recommendations; Neurodegenerative disorders; Policy priorities; Research priorities

Indexed keywords

ALPHA SYNUCLEIN; BIOLOGICAL MARKER; TAR DNA BINDING PROTEIN;

AGING; ALZHEIMER DISEASE; COST EFFECTIVENESS ANALYSIS; DRUG DEVELOPMENT; HEALTH CARE POLICY; HEALTH CARE QUALITY; HEALTH ECONOMICS; HEALTH PROGRAM; HEALTH SERVICE; HUMAN; MEDICAL ETHICS; MEDICAL RESEARCH; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW;

EID: 84866121019     PISSN: 15525260     EISSN: 15525279     Source Type: Journal    
DOI: 10.1016/j.jalz.2012.08.001     Document Type: Note

References (23)

1. United States Department of Health and Human Services, Assistant Secretary for Planning and Evaluation: United States national plan to address Alzheimer's disease, http://aspe.hhs.gov/daltcp/napa/NatlPlan.pdf, Accessed May 16, 2012. 2012.
2. S.M. Paul, D.S. Mytelka, C.T. Dunwiddie, C.C. Persinger, B.H. Munos, S.R. Lindborg, and A.L. Schacht How to improve R&D productivity: The pharmaceutical industry's grand challenge Nat Rev Drug Discov 9 2010 203 214
3. P. Cuatrecasas Interview with Pedro Cuatrecasas Nat Rev Drug Discov 8 2009 446
4. M.W. Weiner, D.P. Veitch, P.S. Aisen, L.A. Beckett, N.J. Cairns, R.C. Green, D. Harvey, C.R. Jack, W. Jagust, and E. Liu The Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception Alzheimers Dement 8 2012 S1 S68
5. J.Q. Trojanowski, S.E. Arnold, J.H. Karlawish, K. Brunden, M. Cary, C. Davatzikos, J. Detre, G. Gaulton, M. Grossman, and H. Hurtig Design of comprehensive Alzheimer's disease centers to address unmet national needs Alzheimers Dement 6 2010 150 155
6. H. Vanderstichele, M. Bibl, S. Engelborghs, N. Le Bastard, P. Lewczuk, J.L. Molinuevo, L. Parnetti, A. Perret-Liaudet, L.M. Shaw, and C. Teunissen Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: a consensus paper from the Alzheimer's Biomarkers Standardization Initiative Alzheimers Dement 8 2012 65 73
7. N. Mattsson, U. Andreasson, S. Persson, H. Arai, S.D. Batish, S. Bernardini, L. Bocchio-Chiavetto, M.A. Blankenstein, M.C. Carrillo, and S. Chalbot The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers Alzheimers Dement 7 2011 386 395
8. Z.S. Khachaturian, D. Barnes, R. Einstein, S. Johnson, V. Lee, A. Roses, M.A. Sager, W.R. Shankle, P.J. Snyder, and R.C. Petersen Developing a national strategy to prevent dementia: Leon Thal Symposium 2009 Alzheimers Dement 6 2010 89 97
9. Z.S. Khachaturian, A.S. Khachaturian, and W. Thies The draft "National Plan" to address Alzheimer's disease - National Alzheimer's Project Act (NAPA) Alzheimers Dement 8 2012 234 236
10. Z.S. Khachaturian, R.C. Petersen, P.J. Snyder, A.S. Khachaturian, P. Aisen, M. de Leon, B.D. Greenberg, W. Kukull, P. Maruff, and R.A. Sperling Developing a global strategy to prevent Alzheimer's disease: Leon Thal Symposium 2010 Alzheimers Dement 7 2011 127 132
11. Z.S. Khachaturian, P.J. Snyder, R. Doody, P. Aisen, M. Comer, J. Dwyer, R.A. Frank, A. Holzapfel, A.S. Khachaturian, and A.D. Korczyn A roadmap for the prevention of dementia II: Leon Thal Symposium 2008 Alzheimers Dement 5 2009 85 92
12. M.S. Albert, S.T. DeKosky, D. Dickson, B. Dubois, H.H. Feldman, N.C. Fox, A. Gamst, D.M. Holtzman, W.J. Jagust, and R.C. Petersen The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging - Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease Alzheimers Dement 7 2011 270 279
13. C.R. Jack Jr., M.S. Albert, D.S. Knopman, G.M. McKhann, R.A. Sperling, M.C. Carrillo, B. Thies, and C.H. Phelps Introduction to the recommendations from the National Institute on Aging - Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease Alzheimers Dement 7 2011 257 262
14. G.M. McKhann, D.S. Knopman, H. Chertkow, B.T. Hyman, C.R. Jack Jr., C.H. Kawas, W.E. Klunk, W.J. Koroshetz, J.J. Manly, and R. Mayeux The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging - Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease Alzheimers Dement 7 2011 263 269
15. R.A. Sperling, P.S. Aisen, L.A. Beckett, D.A. Bennett, S. Craft, A.M. Fagan, T. Iwatsubo, C.R. Jack Jr., J. Kaye, and T.J. Montine Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging - Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease Alzheimers Dement 7 2011 280 292
16. B. Dubois, H.H. Feldman, C. Jacova, J.L. Cummings, S.T. Dekosky, P. Barberger-Gateau, A. Delacourte, G. Frisoni, N.C. Fox, and D. Galasko Revising the definition of Alzheimer's disease: A new lexicon Lancet Neurol 9 2010 1118 1127
17. Z.S. Khachaturian, J. Cami, S. Andrieu, J. Avila, M. Boada Rovira, M. Breteler, L. Froelich, S. Gauthier, T. Gomez-Isla, and A.S. Khachaturian Creating a transatlantic research enterprise for preventing Alzheimer's disease Alzheimers Dement 5 2009 361 366
18. L. Thal, L. Kuller, K. Bowman, J. Breitner, D. Evans, L. Farrer, R. Frank, A.S. Khachaturian, Z.S. Khachaturian, and W. Kukull The Nevada Vital Aging Initiative: A private-public partnership to study early predictors of dementia Alzheimers Dement 3 2007 62 67 (Pubitemid 46076027)
19. M. Buyse, D.J. Sargent, A. Grothey, A. Matheson, and A. de Gramont Biomarkers and surrogate end points - the challenge of statistical validation Nat Rev Clin Oncol 7 2010 309 317
20. H.G. Welch, and W.C. Black Overdiagnosis in cancer J Natl Cancer Inst 102 2010 605 613
21. J.A. Greene Prescribing by numbers: Drugs and the definition of disease 2006 Johns Hopkins University Press Baltimore
22. S. Borson, J.M. Scanlan, M. Lessig, and S. DeMers Comorbidity in aging and dementia: Scales differ, and the difference matters Am J Geriatr Psychiatry 18 2010 999 1006
23. S. Borson Cognition, aging, and disabilities: Conceptual issues Phys Med Rehabil Clin N Am 21 2010 375 382